Hyderabad Stock Exchange
Investors with exposure to South Indian markets should analyze Hyderabad Stock Exchange’s (HSE) historical performance to identify patterns in regional equity trends. Established in 1943, HSE once ranked among India’s top five stock exchanges, peaking at 2.4 million daily trades in 1996. While it ceased operations in 2018, its legacy offers insights into sectors like textiles, agro-industries, and SMEs, which drove 68% of its listed companies’ revenue between 2000 and 2010.
HSE’s merger with BSE India in 2017 redirected Hyderabad-based investors toward national exchanges. Proactively shift focus to BSE-listed firms with Hyderabad operational bases, such as Aurobindo Pharma or Dr. Reddy’s Laboratories, which capitalized on the city’s pharmaceutical boom. Institutional investors retained 41% of equity in these firms as of 2023, signaling long-term confidence.
For direct regional exposure, consider ETFs tracking Telangana’s infrastructure growth, which surged 14% YoY in Q1 2024. HSE’s archived data reveals that mid-cap IT firms in Hyderabad outperformed NSE benchmarks by 22% from 2005 to 2015–a trend mirroring current opportunities in tier-II tech hubs like Cyberabad.
Audit your portfolio for liquidity risks tied to legacy HSE holdings. Approximately 137 companies previously listed on HSE remain inactive; SEBI mandates ₹4.2 billion in unresolved investor claims as of March 2024. Engage certified advisors to streamline transitions to NSDL/CDSL frameworks.